
Novel Approaches to Metastatic HER2+ Breast Cancer
Join us to learn more about how the field in HER2+ breast cancer is evolving and hear direct from leading experts, Debu Tripathy, MD and Michelina Cairo, MD, on Tuesday, October 13, 2020 at 8:00 PM CDT.
Tuesday, October 13, 2020
8:00 PM-9:30 PM CDT
Join us to learn more about how the field in HER2+ breast cancer is evolving and hear direct from leading experts, Debu Tripathy, MD and Michelina Cairo, MD.
Topics of discussion at this virtual event include:
- Review and evaluate data on recent therapeutic advances in metastatic HER2+ breast cancer
- Discuss clinical challenges and areas of uncertainty faced when selecting later lines of therapy for patients with metastatic HER2+ breast cancer
- Identify factors that influence treatment selection and planning for patients with metastatic HER2+ breast cancer
Professor and Chair,
Department of Breast Medical Oncology
UT MD Anderson Cancer Center
Houston, Texas
Texas Oncology
Houston, TX
United States



































